Over 500 are Recruited to the World's Largest Randomised Trial in Interventional Oncology

Published date : 15 April 2013
Article date : 13 April 2013

SIRTEX Medical Limited, a manufacturer of targeted innovative liver cancer therapies has announced the completion of patient recruitment into the group's landmark SIRFLOX randomised controlled trial of SIR-Spheres microspheres, for patients with metastatic colorectal cancer.

The SIRFLOX study is the world's largest randomised controlled trial in interventional oncology, with more than 500 patients enrolled.

Read the manufacturer's press release here (13 April 2013). 

Source: www.pharmiweb.com

Back to Listings

Share |

Find a Device

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.